17

If the Government cannot publish the Impact Assessment for the Pharmaceutical Arrangement, it should publish...

Recommendation
If the Government cannot publish the Impact Assessment for the Pharmaceutical Arrangement, it should publish its evidence that accelerating spend on innovative medicines will increase investment in the UK. (Recommendation, Paragraph 82) 61
Addressee Bodies
Department for Business and Trade
Timeline
Recommendation age 0.1 yrs
Report published 04 Jul 2026